Nonacog Alfa as Prophylaxis in Moderately Severe to Severe (FIX:C <= 2%) Hemophilia B Patients: Identifying Clinical Predictors of Response Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • February 1, 2016